Expression and Potential Role of Fas-Associated Phosphatase-1 in Ovarian Cancer
- 30 April 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (4), 1335-1344
- https://doi.org/10.1016/s0002-9440(10)64084-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Functional interaction of Fas‐associated phosphatase‐1 (FAP‐1) with p75NTR and their effect on NF‐κB activationFEBS Letters, 1999
- Structural Modification of Fas C-Terminal Tripeptide and Its Effects on the Inhibitory Activity of Fas/FAP-1 BindingJournal of Medicinal Chemistry, 1999
- Immunohistochemical localization of FAP‐1, an inhibitor of Fas‐mediated apoptosis, in normal and neoplastic human tissuesAPMIS, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Chemotherapeutic drug‐induced apoptosis in human leukaemic cells is independent of the Fas (APO‐1/CD95) receptor/ligand systemBritish Journal of Haematology, 1998
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapyBritish Journal of Haematology, 1996
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral ActivityJNCI Journal of the National Cancer Institute, 1989
- Aminoalkylsilane-treated glass slides as support forin situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditionsJournal of Molecular Histology, 1986